LEONARD W. ROZAMUS JR.

LEONARD W. ROZAMUS JR.

Founder and President

Len Rozamus is a pharmaceutical executive with extensive experience in the discovery and development of active pharmaceutical ingredients. Len is an organic chemist, who began his career in medicinal chemistry at SmithKline Beecham and later moved into process development and the management of outsourced contract manufacturing to support clinical development programs at ARIAD Pharmaceuticals, Inc. At ARIAD, Len provided leadership to multi-disciplinary teams in every aspect of CMC development for pre-clinical assets through commercial production, primarily in support of challenging fast-track and breakthrough medications. During that time Len contributed to five Investigational New Drug applications (INDs) and three New Drug Applications (NDAs), resulting in two approved therapeutic agents for oncology and an approved drug eluting stent. As the founder of Rozamus and Associates, Inc. Len seeks to provide strategic and operational guidance to both large and small companies for pharmaceutical product life-cycle management.
Gary Allmaier, Ph.D.

Gary Allmaier, Ph.D.

Senior Consultant

Dr. Gary Allmaier has worked in the Pharmaceutical Industry for over 35 years, specializing in Pharmaceutical Development with an Analytical Development focus. Gary studied Pharmaceutical Sciences at Rutgers University, where he earned both a M.S. and Ph.D. degree in that field. Gary possesses a diverse work background, including small and large pharmaceutical companies, as well as generics, OTC’s, and a non-profit organization. Gary is passionate about healthcare, and his efforts in the Pharmaceutical Industry have resulted in several new drugs being approved by the FDA for patient use in the U.S. and worldwide. In addition to his passion for patients, Gary has completed 10 full marathons and is a 10-handicap golfer.
Christine Bennett

Christine J. Bennett

Sr. Technical Writer

Christine J. Bennett is a pharmaceutical documentation specialist with over twenty years of technical writing experience. In her most recent consulting job with Shire, she focused on the project management of R&D procedural documentation and participated extensively with the creation of new documentation. Previously, at ARIAD Pharmaceuticals, she was the documentation specialist for the Technical Operations department, creating, tracking, and submitting documents in support of Investigational New Drug applications (INDs) and New Drug Applications (NDAs). Christine aims to lighten the load of subject matter experts by overseeing documents from creation through approval.